464 related articles for article (PubMed ID: 28184937)
1. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
Cho JH; Chae JI; Shim JH
Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
[TBL] [Abstract][Full Text] [Related]
2. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
[TBL] [Abstract][Full Text] [Related]
3. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
[TBL] [Abstract][Full Text] [Related]
4. The prolyl isomerase Pin1 interacts with and downregulates the activity of AMPK leading to induction of tumorigenicity of hepatocarcinoma cells.
Khanal P; Kim G; Yun HJ; Cho HG; Choi HS
Mol Carcinog; 2013 Oct; 52(10):813-23. PubMed ID: 22549912
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
Finn G; Lu KP
Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.
Zhou XZ; Lu PJ; Wulf G; Lu KP
Cell Mol Life Sci; 1999 Nov; 56(9-10):788-806. PubMed ID: 11212339
[TBL] [Abstract][Full Text] [Related]
7. Dual Roles of Pin1 in Cancer Development and Progression.
Han HJ; Choi BY; Surh YJ
Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058
[TBL] [Abstract][Full Text] [Related]
8. Pin1 as an anticancer drug target.
Xu GG; Etzkorn FA
Drug News Perspect; 2009 Sep; 22(7):399-407. PubMed ID: 19890497
[TBL] [Abstract][Full Text] [Related]
9. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
[TBL] [Abstract][Full Text] [Related]
10. The role of Pin1 in the development and treatment of cancer.
Min SH; Zhou XZ; Lu KP
Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155
[TBL] [Abstract][Full Text] [Related]
11. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.
Wulf GM; Ryo A; Wulf GG; Lee SW; Niu T; Petkova V; Lu KP
EMBO J; 2001 Jul; 20(13):3459-72. PubMed ID: 11432833
[TBL] [Abstract][Full Text] [Related]
12. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
Marsolier J; Weitzman JB
Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
[TBL] [Abstract][Full Text] [Related]
13. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
[TBL] [Abstract][Full Text] [Related]
14. A critical step for JNK activation: isomerization by the prolyl isomerase Pin1.
Park JE; Lee JA; Park SG; Lee DH; Kim SJ; Kim HJ; Uchida C; Uchida T; Park BC; Cho S
Cell Death Differ; 2012 Jan; 19(1):153-61. PubMed ID: 21660049
[TBL] [Abstract][Full Text] [Related]
15. Targeting carcinogenesis: a role for the prolyl isomerase Pin1?
Lu KP; Suizu F; Zhou XZ; Finn G; Lam P; Wulf G
Mol Carcinog; 2006 Jun; 45(6):397-402. PubMed ID: 16652378
[TBL] [Abstract][Full Text] [Related]
16. The Peptidyl-Prolyl
Anto NP; Muraleedharan A; Nath PR; Sun Z; Keasar C; Livneh E; Braiman A; Altman A; Kong KF; Isakov N
Front Immunol; 2023; 14():1126464. PubMed ID: 36969236
[TBL] [Abstract][Full Text] [Related]
17. Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase.
Chen XR; Igumenova TI
Adv Biol Regul; 2023 Jan; 87():100938. PubMed ID: 36496344
[TBL] [Abstract][Full Text] [Related]
18. PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin.
Cheng CW; Chow AK; Pang R; Fok EW; Kwong YL; Tse E
Am J Pathol; 2013 Mar; 182(3):765-75. PubMed ID: 23333752
[TBL] [Abstract][Full Text] [Related]
19. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
Ryo A; Liou YC; Lu KP; Wulf G
J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
[TBL] [Abstract][Full Text] [Related]
20. Prevalent overexpression of prolyl isomerase Pin1 in human cancers.
Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG
Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
